🔴 Immunic is trading 10% down today with no confirmed company-specific catalyst

Immunic is trading 10.46% down at $12.75 now, with no confirmed company-specific negative catalyst emerging for September 3, 2026.

• The latest announcement, dated September 2, concerns a September 9 virtual relapsing-MS R&D Day ahead of expected Phase 3 ENSURE data by year-end.
• It reported no new clinical results, financing, or adverse regulatory developments.
• Biotechnology and broader markets are rising; the decline appears stock-specific, potentially reflecting profit-taking or trading pressure.